Home Ingredients AmealPeptide® (Casein Lactotripeptides VPP and IPP)
Cardiovascular

AmealPeptide® (Casein Lactotripeptides VPP and IPP)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

AmealPeptide® is a casein-derived ingredient supplying the lactotripeptides VPP (valyl-prolyl-proline) and IPP (isoleucyl-prolyl-proline), developed from a fermentation process pioneered with the Calpis fermented-milk tradition. These small milk peptides act like a gentle, natural ACE inhibitor and are studied for supporting healthy blood pressure.

Studied Dose Around 3 to 4 mg of combined VPP and IPP per day.
Active Compound Casein-derived lactotripeptides valyl-prolyl-proline (VPP) and isoleucyl-prolyl-proline (IPP).

Benefits

Healthy blood pressure

A meta-analysis of randomized trials found the lactotripeptides VPP and IPP produced a modest reduction in systolic blood pressure, supporting their blood-pressure positioning.

Supported by Trial 1

Arterial elasticity

By gently inhibiting the ACE enzyme, the peptides support relaxed, flexible blood vessels.

Supported by Trial 1

Natural ACE-inhibitor action

The peptides offer a food-derived way to support the body's blood-pressure regulation, with a strong safety record.

Mechanism of action

1

ACE inhibition

VPP and IPP inhibit angiotensin-converting enzyme (ACE), reducing formation of the vessel-constricting hormone angiotensin II and supporting lower blood pressure.

2

Vascular support

Lower angiotensin II activity helps blood vessels stay relaxed, supporting healthy circulation.

Clinical trials

1
Lactotripeptides and Blood Pressure — Meta-Analysis
PubMed

Meta-analysis of randomized controlled trials of the lactotripeptides IPP and VPP on systolic blood pressure in European subjects. (Cicero et al. 2013, American Journal of Hypertension)

Adults across multiple RCTs.

The lactotripeptides produced a modest but statistically significant reduction in systolic blood pressure versus placebo.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — derived from milk protein.
Mild digestive upset is occasionally reported.
Avoid if you have a milk-protein allergy.

Important Drug interactions

Blood pressure medication — possible additive effect; monitor.
ACE inhibitors — theoretical additive effect; tell your doctor.
Tell your doctor if you take cardiovascular medication.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin, or vitamin B3, is a vital nutrient that supports energy production by serving as a…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Frequently asked questions about AmealPeptide® (Casein Lactotripeptides VPP and IPP)

What is AmealPeptide® (Casein Lactotripeptides VPP and IPP)?

AmealPeptide® is a casein-derived ingredient supplying the lactotripeptides VPP (valyl-prolyl-proline) and IPP (isoleucyl-prolyl-proline), developed from a fermentation process pioneered with the Calpis fermented-milk tradition.

What is the recommended dosage of AmealPeptide® (Casein Lactotripeptides VPP and IPP)?

The clinically studied dose for AmealPeptide® (Casein Lactotripeptides VPP and IPP) is Around 3 to 4 mg of combined VPP and IPP per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is AmealPeptide® (Casein Lactotripeptides VPP and IPP) used for?

AmealPeptide® (Casein Lactotripeptides VPP and IPP) is studied for healthy blood pressure, arterial elasticity, natural ace-inhibitor action. A meta-analysis of randomized trials found the lactotripeptides VPP and IPP produced a modest reduction in systolic blood pressure, supporting their blood-pressure positioning.

Are there side effects from taking AmealPeptide® (Casein Lactotripeptides VPP and IPP)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — derived from milk protein. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is AmealPeptide® (Casein Lactotripeptides VPP and IPP) safe to take?

Whether AmealPeptide® (Casein Lactotripeptides VPP and IPP) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — derived from milk protein. It may also interact with certain medications. AmealPeptide® (Casein Lactotripeptides VPP and IPP) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cicero AF, Aubin F, Azais-Braesco V, et al. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens. 2013;26(3):442-9..PubMedUsed to support: Meta-analysis supporting modest blood-pressure benefit of lactotripeptides.